SCHEMBL9843100

SCHEMBL9843100

Nc1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I.Nc1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I.O=C(O)C(O)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.52
CYP2C19 P33261 1/20 0.52
HIF1A Q16665 1/20 0.52
EGFR P00533 1/20 0.36
SRC P12931 1/20 0.36
MAP2K1 Q02750 7/20 0.34
MAP2K2 P36507 2/20 0.34
PRKCZ Q05513 1/20 0.34
IARS2 Q9NSE4 1/20 0.34
CA2 P00918 1/20 0.33
CNR2 P34972 1/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
HPGD P15428 1/20 0.32
BACE1 P56817 1/20 0.31
TYMP P19971 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL619959 0.93 LMNA (0.58) LMNACYP2C19HIF1AEGFRSRC
SCHEMBL9761063 0.92 LMNA (0.46) LMNACYP2C19HIF1AEGFRSRC
SCHEMBL8063055 0.90 LMNA (0.53) LMNACYP2C19HIF1AEGFRSRC
SCHEMBL32668972 0.90 LMNA (0.53) LMNACYP2C19HIF1AEGFRSRC
Malonic Acid SCHEMBL11131957 0.90 LMNA (0.53) LMNACYP2C19HIF1AEGFRSRC
SCHEMBL9513442 0.90 LMNA (0.55) LMNACYP2C19HIF1AEGFRSRC
SCHEMBL28469692 0.88 LMNA (0.54) LMNACYP2C19HIF1AEGFRSRC
SCHEMBL9191548 0.88 LMNA (0.54) LMNACYP2C19HIF1AEGFRSRC
SCHEMBL621824 0.86 LMNA (0.52) LMNACYP2C19HIF1AEGFRSRC
Cadaverine Tartrate SCHEMBL9760947 0.85 LMNA (0.47) LMNACYP2C19HIF1AEGFRSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5004835-A Substituted dicarboxylic acid-bis(3,5-dicarbamoyl-2,4,6-triiodoanilides), process for their production as well as X-ray contrast media containing them SCHERING AKTIENGESELLSCHAFT (DE) 1991-04-02 US disclosed